Bi-Sifrol Tablets 0.5mg, manufactured by Nippon Boehringer Ingelheim, contain Pramipexole hydrochloride hydrate. This medication is used to treat Parkinson’s disease by stimulating dopamine D2 receptors in the brain, and also for idiopathic restless legs syndrome. Its YJ code is 1169012F2029, with a standard dosage of 0.5 mg per tablet.
Bi-Sifrol Tablets 0.5mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).